CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Delisting notice
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change
- 8-K Event Executive or director change
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Delisting notice
- 8-K Event Executive or director change
Page 5 of 12 · 221 filings